from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1281c/oppD

LFCtreatmentdescriptionclass of inhibitor

-1.422

Amikacinug/mL Amikacintranslation

-0.636

Cap5-10ug/mL Capreomycintranslation

-0.777

Rox10-50 ug/mL Roxithromycintranslation

0.354

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.483

Rif0.2-5ug/mL Rifampicintranscription

0.106

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.469

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.505

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.507

CPZ10-50 ug/mL Chlorpromazinerespiration

0.051

Clofazimine10-13 ug/mL Clofaziminerespiration

1.374

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.530

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.115

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.644

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.165

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.381

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.087

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.062

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.084

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.385

KCN5-20 ug/mL Potassium cyaniderespiration

0.395

NaN30.2-2 mM Sodium aziderespiration

0.594

Nigericin50 uM Nigericinrespiration

-0.227

TRC10-150 ug/mL Triclosanrespiration

-0.751

TRZ10-25 ug/mL Thioridazinerespiration

-1.375

Valinomycin0.5-10 uM Valinomycinrespiration

0.016

ZnSO42 mM ZnSO4respiration

-0.513

menadione6-10 ug/mL Menadionerespiration

0.134

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.808

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.482

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.748

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.131

NRP_1Non-replicating persistence stage 1dosRassociated

0.212

Amp0.2mg/mL AmpicillincellWall

0.356

Cephalexin20-100 ug/mL CephalexincellWall

0.719

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.120

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.372

EMB10-20 ug/mL EthambutolcellWall

0.443

Eta12-40 ug/mL EthionamidecellWall

0.547

INH0.2-0.4 ug/mL IsoniazidcellWall

0.448

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.515

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.008

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.133

BZA0.12 mg/mL BenzamidearomaticAmides

0.056

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.315

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.357

H2O24 mM hydrogen peroxideDNAdamaging

0.155

Levo10 ug/mL LevofloxacinDNAdamaging

-0.312

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.673

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.066

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.705

UVUV-irradiationDNAdamaging

-0.596

ARP41-4 ug/mL Antitubercular compound ARP4?

1.029

Antimycin12.5-50 ug/mL Antimycin A?

0.709

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.104

PA_110-50 ug/mL Antitubercular compound PA-1?

1.002

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.227

PA8240.2-2 ug/mL PA-824?

-2.554

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.173

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.574

Verapamil50 uM Verapamil?

0.551

mercaptoethanol2 mM 2-Mercaptoethanol?

0.982

methoxatin10-20 ug/mL Methoxatin?